Featured Archives - Page 17 of 22

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

THIS WEEK'S STORIES

Cyberattacks Disrupt Patient Care in Nearly 1 in 5 Healthcare Organizations, Omega Systems Report Finds

June 4, 2025

Enveric Biosciences Secures U.S. Patent for Novel Melatonin Receptor-Targeting Compounds

June 3, 2025

Bambusa Therapeutics Doses First Subject in Phase 1 Trial of Novel Bispecific Antibody BBT002, Gains FDA Clearance for BBT001 IND

May 31, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

Most Read

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

Suffolk Unveils White Paper to Drive Climate Tech Adoption in Construction Industry

Tracer Biotechnologies Partners with QIAGEN to Expand Blood-Based Cancer Testing

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

EDITOR PICKS

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

THIS WEEK'S STORIES

Cyberattacks Disrupt Patient Care in Nearly 1 in 5 Healthcare Organizations, Omega Systems Report Finds

Enveric Biosciences Secures U.S. Patent for Novel Melatonin Receptor-Targeting Compounds

Bambusa Therapeutics Doses First Subject in Phase 1 Trial of Novel Bispecific Antibody BBT002, Gains FDA Clearance for BBT001 IND

POPULAR CATEGORY

ABOUT US

FOLLOW US